• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫相关基因在非酒精性脂肪性肝病不同阶段的表达及可能的调控机制。

Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.

机构信息

Department of Pancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

出版信息

Front Immunol. 2024 Mar 8;15:1364442. doi: 10.3389/fimmu.2024.1364442. eCollection 2024.

DOI:10.3389/fimmu.2024.1364442
PMID:38524129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10957650/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD), which includes simple steatosis (SS) and non-alcoholic steatohepatitis (NASH), is a significant contributor to liver disease on a global scale. The change of immunity-related genes (IRGs) expression level leads to different immune infiltrations. However, the expression of IRGs and possible regulatory mechanisms involved in NAFLD remain unclear. The objective of our research is to investigate crucial genes linked to the development of NAFLD and the transition from SS to NASH.

METHODS

Dataset GSE89632, which includes healthy controls, SS patients, and NASH patients, was obtained using the GEO database. To examine the correlation between sets of genes and clinical characteristics, we employed weighted gene co-expression network analysis (WGCNA) and differential expression analysis. Hub genes were extracted using a network of protein-protein interactions (PPI) and three different machine learning algorithms. To validate the findings, another dataset that is publicly accessible and mice that were subjected to a high-fat diet (HFD) or MCD diet were utilized. Furthermore, the ESTIMATE algorithm and ssGSEA were employed to investigate the immune landscape in the normal versus SS group and SS versus NASH group, additionally, the relationship between immune infiltration and the expression of hub genes was also examined.

RESULTS

A total of 28 immune related key genes were selected. Most of these genes expressed reverse patterns in the initial and progressive stages of NAFLD. GO and KEGG analyses showed that they were focused on the cytokine related pathways and immune cell activation and chemotaxis. After screening by various algorithms, we obtained two hub genes, including JUN and CCL20. Validation of these findings was confirmed by analyzing gene expression patterns in both the validation dataset and the mouse model. Ultimately, two hub genes were discovered to have a significant correlation with the infiltration of immune cells.

CONCLUSION

We proposed that there were dynamic changes in the expression levels of IRGs in different stages of NAFLD disease, which led to different immune landscapes in SS and NASH. The findings of our research could serve as a guide for the accurate management of various phases of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)包括单纯性脂肪变性(SS)和非酒精性脂肪性肝炎(NASH),是全球范围内导致肝病的一个重要因素。免疫相关基因(IRGs)表达水平的变化导致了不同的免疫浸润。然而,NAFLD 中涉及的 IRGs 的表达和可能的调节机制仍不清楚。我们的研究目的是研究与 NAFLD 发展以及从 SS 向 NASH 转变相关的关键基因。

方法

从 GEO 数据库中获取了包含健康对照组、SS 患者和 NASH 患者的数据集 GSE89632。为了研究基因集与临床特征之间的相关性,我们采用了加权基因共表达网络分析(WGCNA)和差异表达分析。使用蛋白质-蛋白质相互作用(PPI)网络和三种不同的机器学习算法提取了枢纽基因。为了验证研究结果,我们还使用了另一个公开的数据集和接受高脂肪饮食(HFD)或 MCD 饮食的小鼠。此外,还使用 ESTIMATE 算法和 ssGSEA 来研究正常与 SS 组以及 SS 与 NASH 组之间的免疫图谱,同时还研究了免疫浸润与枢纽基因表达之间的关系。

结果

共选择了 28 个与免疫相关的关键基因。这些基因中的大多数在 NAFLD 的初始和进展阶段表达相反的模式。GO 和 KEGG 分析表明,它们主要集中在细胞因子相关途径和免疫细胞激活和趋化作用上。通过各种算法筛选后,我们获得了两个枢纽基因,包括 JUN 和 CCL20。通过验证数据集和小鼠模型中的基因表达模式,验证了这些发现。最终,发现两个枢纽基因与免疫细胞的浸润有显著相关性。

结论

我们提出,在 NAFLD 疾病的不同阶段,IRGs 的表达水平存在动态变化,导致 SS 和 NASH 中存在不同的免疫图谱。我们的研究结果可以为 NAFLD 各个阶段的准确管理提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/4e2b28e6e8a5/fimmu-15-1364442-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/2dbf778f2fa8/fimmu-15-1364442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/3e5e69a573fb/fimmu-15-1364442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/de70e82f1e3b/fimmu-15-1364442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/4652ba34a417/fimmu-15-1364442-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/2c0693bf81e1/fimmu-15-1364442-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/7eec8027c7a7/fimmu-15-1364442-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/93d7aae7ab77/fimmu-15-1364442-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/285ab8eec497/fimmu-15-1364442-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/7e020680f216/fimmu-15-1364442-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/4e2b28e6e8a5/fimmu-15-1364442-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/2dbf778f2fa8/fimmu-15-1364442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/3e5e69a573fb/fimmu-15-1364442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/de70e82f1e3b/fimmu-15-1364442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/4652ba34a417/fimmu-15-1364442-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/2c0693bf81e1/fimmu-15-1364442-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/7eec8027c7a7/fimmu-15-1364442-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/93d7aae7ab77/fimmu-15-1364442-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/285ab8eec497/fimmu-15-1364442-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/7e020680f216/fimmu-15-1364442-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9831/10957650/4e2b28e6e8a5/fimmu-15-1364442-g010.jpg

相似文献

1
Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.免疫相关基因在非酒精性脂肪性肝病不同阶段的表达及可能的调控机制。
Front Immunol. 2024 Mar 8;15:1364442. doi: 10.3389/fimmu.2024.1364442. eCollection 2024.
2
Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.基于机器学习和加权基因共表达网络分析的整合分析确定非酒精性脂肪性肝病的氧化应激生物标志物。
Front Immunol. 2024 Feb 27;15:1335112. doi: 10.3389/fimmu.2024.1335112. eCollection 2024.
3
[Analysis of hub genes and molecular mechanisms in non-alcoholic steatohepatitis based on the gene expression omnibus database].基于基因表达综合数据库的非酒精性脂肪性肝炎中枢纽基因及分子机制分析
Zhonghua Yi Xue Za Zhi. 2021 Nov 2;101(40):3317-3322. doi: 10.3760/cma.j.cn112137-20210416-00913.
4
Identification of Hub Genes Associated With Non-alcoholic Steatohepatitis Using Integrated Bioinformatics Analysis.运用综合生物信息学分析鉴定非酒精性脂肪性肝炎相关枢纽基因
Front Genet. 2022 Apr 26;13:872518. doi: 10.3389/fgene.2022.872518. eCollection 2022.
5
CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis.趋化因子 (C-X-C 基元) 配体 9、白细胞介素 2 受体亚基 β 和分泌磷蛋白 1,动脉粥样硬化和非酒精性脂肪性肝炎合并症模式中的潜在诊断生物标志物。
Sci Rep. 2024 Jul 16;14(1):16364. doi: 10.1038/s41598-024-66287-4.
6
Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning.基于生物信息学分析和机器学习的非酒精性脂肪性肝病(NAFLD)合并慢性肾脏病(CKD)诊断生物标志物的鉴定。
Front Endocrinol (Lausanne). 2023 Feb 27;14:1125829. doi: 10.3389/fendo.2023.1125829. eCollection 2023.
7
A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.高脂肪饮食和蛋氨酸-胆碱缺乏饮食动物模型中非酒精性脂肪性肝病基因表达谱的比较。
Molecules. 2022 Jan 27;27(3):858. doi: 10.3390/molecules27030858.
8
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.Gasdermin D 在人类和小鼠的非酒精性脂肪性肝炎中作为细胞焦亡的效应蛋白发挥关键作用。
J Hepatol. 2018 Apr;68(4):773-782. doi: 10.1016/j.jhep.2017.11.040. Epub 2017 Dec 20.
9
Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.通过生物信息学和实验分析鉴定核糖体蛋白家族作为 NAFLD 的免疫细胞相关生物标志物。
Front Endocrinol (Lausanne). 2023 May 19;14:1161269. doi: 10.3389/fendo.2023.1161269. eCollection 2023.
10
Identification of Autophagy-Related Genes in the Progression from Non-Alcoholic Fatty Liver to Non-Alcoholic Steatohepatitis.非酒精性脂肪肝向非酒精性脂肪性肝炎进展过程中自噬相关基因的鉴定
Int J Gen Med. 2021 Jul 5;14:3163-3176. doi: 10.2147/IJGM.S317785. eCollection 2021.

引用本文的文献

1
Identifying shared hub genes in LIRI and MASLD through bioinformatics analysis and machine learning.通过生物信息学分析和机器学习识别肝缺血再灌注损伤(LIRI)和代谢相关脂肪性肝病(MASLD)中的共享枢纽基因。
Sci Rep. 2025 May 27;15(1):18532. doi: 10.1038/s41598-025-01609-8.
2
Lactate transporter MCT4 regulates the hub genes for lipid metabolism and inflammation to attenuate intracellular lipid accumulation in non-alcoholic fatty liver disease.乳酸转运体MCT4通过调节脂质代谢和炎症的枢纽基因来减轻非酒精性脂肪性肝病中的细胞内脂质积累。
Genes Dis. 2025 Feb 15;12(4):101554. doi: 10.1016/j.gendis.2025.101554. eCollection 2025 Jul.
3
Identification of diagnostic genes and the miRNA‒mRNA‒TF regulatory network in human oocyte aging via machine learning methods.

本文引用的文献

1
Transcriptomics reveal a molecular signature in the progression of nonalcoholic steatohepatitis and identifies PAI‑1 and MMP‑9 as biomarkers in and studies.转录组学揭示了非酒精性脂肪性肝炎进展过程中的分子特征,并确定了 PAI-1 和 MMP-9 作为 和 研究中的生物标志物。
Mol Med Rep. 2024 Jan;29(1). doi: 10.3892/mmr.2023.13138. Epub 2023 Dec 1.
2
Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study.将糖尿病、性别和绝经期结合起来作为与 II 类和 III 类肥胖个体的 NASH 和肝纤维化相关的有意义的临床特征:一项回顾性队列研究。
Obesity (Silver Spring). 2023 Dec;31(12):3066-3076. doi: 10.1002/oby.23904.
3
通过机器学习方法鉴定人类卵母细胞衰老中的诊断基因及miRNA-mRNA-TF调控网络。
J Assist Reprod Genet. 2025 Jan;42(1):319-333. doi: 10.1007/s10815-024-03311-6. Epub 2024 Nov 14.
Identification of biomarkers associated with immune-propionate metabolism in nonalcoholic fatty liver disease.
非酒精性脂肪性肝病中与免疫丙酸代谢相关的生物标志物的鉴定
Cell Mol Biol (Noisy-le-grand). 2023 Oct 31;69(10):254-263. doi: 10.14715/cmb/2023.69.10.38.
4
Comparative Analysis of Global Hepatic Gene Expression in Adolescents and Adults with Non-alcoholic Fatty Liver Disease.青少年和成人非酒精性脂肪性肝病患者肝脏基因表达的全球比较分析
Arch Clin Biomed Res. 2023;7(1):112-119. doi: 10.26502/acbr.50170323. Epub 2023 Feb 20.
5
Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease.非酒精性脂肪性肝病小鼠和人类的肝转录组特征。
Animal Model Exp Med. 2023 Aug;6(4):317-328. doi: 10.1002/ame2.12338. Epub 2023 Aug 11.
6
Identification of key modules and driving genes in nonalcoholic fatty liver disease by weighted gene co-expression network analysis.基于加权基因共表达网络分析鉴定非酒精性脂肪性肝病的关键模块和驱动基因。
BMC Genomics. 2023 Jul 24;24(1):414. doi: 10.1186/s12864-023-09458-3.
7
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.不断演变的肿瘤微环境:从癌症起始到转移灶生长
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
8
Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation.免疫反应在非酒精性脂肪性肝病相关肝癌的发生发展中的作用及治疗调节的前景。
J Hepatol. 2023 Aug;79(2):538-551. doi: 10.1016/j.jhep.2023.02.033. Epub 2023 Mar 7.
9
Crucial role of T cells in NAFLD-related disease: A review and prospect.T 细胞在非酒精性脂肪性肝病相关疾病中的关键作用:综述与展望。
Front Endocrinol (Lausanne). 2022 Nov 15;13:1051076. doi: 10.3389/fendo.2022.1051076. eCollection 2022.
10
Neuroimmune transcriptome changes in patient brains of psychiatric and neurological disorders.神经免疫转录组在精神和神经疾病患者大脑中的变化。
Mol Psychiatry. 2023 Feb;28(2):710-721. doi: 10.1038/s41380-022-01854-7. Epub 2022 Nov 24.